The Chief Medical Officer recently highlighted the urgent nature of antimicrobial resistance. Undoubtedly, the solution is a complex and international one; antimicrobial resistance is as much an industrial and innovation policy issue as it is a health concern. But we believe the problem is tractable given sufficient research effort; with the right approaches, it can be solved. We therefore support moves to develop a cross-sector antimicrobial resistance research strategy that builds on existing initiatives and UK research excellence.
